In the waning days of the Bush administration, the Food and Drug Administration finalized new guidelines to make it easier for drug manufacturers to promote "off-label" prescription drug uses, which can be deadly for patients.
The move came despite criticism from Bush's own Department of Veterans Affairs, which said the change "favors business interests over public safety" and could lead to a "decline in drug safety." It also was crafted despite efforts by state and federal law-enforcement experts to clamp down on off-label drug marketing.
Late move on drugs by Bush FDA could be dangerous
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
